Skip to main content
HNGE logo

HNGE

Hinge Health, Inc.
$90.00 +1.20 (+1.35%) At close · Jul 13
Market Cap
$6.96B
Shares
77,380,129

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$90.00 Open$91.05 Day$88.59–91.50 52W$30.08–91.50 Avg vol 30d2.0M Short int6.7M · 8.7% float · 2.2d Short vol30% Last earningsMay 5, 2026 DataMay 2025–Jul 2026 Filing10-Q · May 7
Up next
Next earnings call
Aug 4, 2026 Est · unconfirmed · in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 7, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Equibles Rating blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Bearish Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 16.5 · calm Equity put/call 0.62
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +81%
      above
      Price vs 50-day avg +39%
      above
      RSI (14) 83
      overbought
      MACD trend Positive
      52-week position 98%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +39%
      trailing
      6-month return +108%
      trailing
      YTD return +94%
      this year
      Relative strength +99%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $65 › 200d $50 — 50d above 200d
      Institutional flow Distributing
      7 of 203 funds reported for Jun 30 · net -39.8K sh shares · +2 new
      Insider flow Distributing
      Net -$26.8M over 90 days · 100% sells
      Short interest Rising
      8.67% of float · ▲ +16.1% MoM · 2.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      203 holders — near 1-yr high, broad support
      Squeeze score 66
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +51%
      Y/Y
      Gross margin 80%
      expanding
      EPS growth −783%
      Y/Y
      Free cash flow $170.7M
      Buyback $80.0M
      remaining
      Balance sheet $208.0M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 60%
      annualized · 1-yr
      Max drawdown −49%
      past year
      ATR 3.9%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record
      Latest guidance · from the 8-K filed May 5, 2026
      Q2 2026
      Revenue Initiated $194M – $196M
      prior qtr $182.31M midpoint +7.0% QoQ
      Non-GAAP income from operations Non-GAAP Initiated $47M – $49M
      Non-GAAP operating margin Non-GAAP Initiated 25%
      Full Year 2026
      Revenue Initiated $798M – $804M
      prior FY $587.86M midpoint +36.3% Y/Y
      Non-GAAP income from operations Non-GAAP Initiated $205M – $215M
      Non-GAAP operating margin Non-GAAP Initiated 26%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 2 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +81% Bullish
      Price vs 50-day avg
      +39% Bullish
      RSI (14)
      83 Bearish
      MACD trend
      Positive Bullish
      52-week position
      98% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 3 of 6
      Trend (MA cross) No cross
      50d $65 › 200d $50 — 50d above 200d
      Institutional flow Distributing
      7 of 203 funds reported for Jun 30 · net -39.8K sh shares · +2 new
      Insider flow Distributing
      Net -$26.8M over 90 days · 100% sells
      Short interest Rising
      8.67% of float · ▲ +16.1% MoM · 2.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      203 holders — near 1-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $30 Now $90 · 98% 52-wk high $92
      vs 200-day avg +81% vs 50-day avg +39%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      gross margin non-GAAP 85% Q1 FY2026 call
      operating margin non-GAAP 25% Q1 FY2026 call
      Annual yield 3.9% 2025
      LTM average eligible lives 20.1M As of December 31, 2025
      Non-GAAP gross margin non-GAAP 85% Q4 2025
      Non-GAAP income from operations non-GAAP $119.5M Year Ended 2025
      Number of contracted lives 25M As of December 31, 2025
      Number of members 782,890 As of December 31, 2025
      Rule of 40 non-GAAP 81 2025

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Health Information Services — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      HNGE
      Hinge Health, Inc.
      this stock
      $6.96B +93.8% +50.6% 8.7%
      VEEV
      Veeva Systems Inc
      $31.37B -13.5% +28.1% 34.2 4.6%
      PMDIY
      Pro Medicus Ltd./ADR
      $15.67B -9.4% 0.0%
      BTSG
      BrightSpring Health Services, Inc.
      $13.51B +86.0% -0.4% 49.8 6.6%
      TEM
      Tempus AI, Inc.
      $10.04B -5.3% +65.8% 18.7%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      203
      % held
      71.7%
      Reported
      7 of 203
      Top holder
      Insight Holdings Group, L…
      Held Float
      View
      Held by Funds
      Fund positions
      119
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      6.7M
      Days to cover
      2.2d
      Change
      +932.0K sh
      View
      Short Volume
      Short vol %
      30%
      As of
      Jul 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      294
      Value
      $18.7K
      As of
      Jun 8, 2026
      View
      Off-Exchange
      Off-exchange %
      44.2%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$26.8M
      Buyers / Sellers
      0 / 5
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $587.9M
      Net income (FY)
      $-528.3M
      EPS diluted
      $-7.77
      View
      Buybacks
      Authorized
      $250.0M
      Remaining
      $80.0M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 9, 2026
      This year
      8
      View
      Proposed Sales
      Value
      $1.6M
      Shares
      17.4K
      Filed
      Jul 7, 2026
      View
      Exempt Offerings
      Offering
      $400.0M
      Filed
      Dec 28, 2023
      View
      Earnings & Events
      Earnings Calls
      Last call
      May 5, 2026
      View
      Investor Relations
      Latest news
      Hinge Health to announce second q…
      Published
      Jul 6, 2026
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      HNGE +1.7% +39.0% +107.7% +8.4% +93.8%
      SPY -0.3% +1.6% +8.3% +0.3% +9.9%
      vs SPY +2.0% +37.5% +99.4% +8.1% +83.9%

      Capital returns

      Buyback program · as of Mar 31, 2026
      Authorized
      $250.00M
      Spent (derived)
      $170.00M
      Remaining
      $80.00M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1673743 CUSIP 433313103 13F (30d) 5 filings 5 filers Visit website Investor relations